Stocks Screeners Features Pricing
Sign In Get Started

UnitedHealth Group Stock Analysis

NYSE: UNH | Health Care | Managed Health Care
Price $415.36 +$0.96 (+0.23%)
P/E Ratio 24.8 TTM
52-Week Range
Low $237 High $462
ROE 12.8% Annual

Market data as of Aug 3, 2026 · Financials as of Dec 2025

Published Jun 22, 2026 · Updated Jul 25, 2026

A fundamental analysis of UnitedHealth Group (UNH) covering revenue trends, profitability, dividends, balance sheet health, and valuation.

UnitedHealth Group's Revenue Performance

In FY2025, UnitedHealth Group posted revenue of $447.57B, up 11.8% from $400.28B a year earlier.

A 11.0% CAGR over 10 years puts UnitedHealth Group in solid growth territory. The top line went from $157.11B to $447.57B in that span.

In terms of scale, UnitedHealth Group's $447.57B in annual revenue positions it as a large-cap health care company.

UnitedHealth Group has posted revenue growth for 10 consecutive years, that's a sustained trend, not a one-off.

Revenue Trend
Year Revenue YoY %
FY2025 $447.57B +11.8%
FY2024 $400.28B +7.7%
FY2023 $371.62B +14.6%
FY2022 $324.16B +12.7%
FY2021 $287.60B +11.8%

View the detailed revenue trend and growth analysis

Revenue by Segment

UnitedHealth Group reports revenue across 4 product segments. Here's the FY2025 breakdown.

Revenue by Product Segment (FY2025)

UnitedHealthcare77.3% · $342.73B
Optum Rx13.0% · $57.68B
Optum Health8.3% · $36.87B
Optum Insight1.4% · $6.37B
SegmentRevenue% of Total
UnitedHealthcare$342.73B77.3%
Optum Rx$57.68B13.0%
Optum Health$36.87B8.3%
Optum Insight$6.37B1.4%

UnitedHealthcare makes up 77.3% of revenue, clearly the primary business for UnitedHealth Group.

Profitability

Net income for UnitedHealth Group weakened to $12.06B in FY2025, 16.3% lower than the $14.40B posted in FY2024.

Margin pressure was evident, with net margin declining to 2.7% from 3.6%.

On a per-share basis, diluted earnings were $13.23 in FY2025 versus $15.51 in FY2024.

Explore the profitability trend in detail below

UnitedHealth Group Shareholder Returns

Shareholders received $8.70 per share in dividends during FY2025, a yield of about 2.07%.

The dividend track record is notable: UnitedHealth Group has maintained payouts for 10+ straight years.

The 65.8% payout ratio suggests the dividend is comfortably covered by earnings, with room to grow.

Dividend History
Year DPS Payout Ratio
FY2025 $8.70 65.8%
FY2024 $8.11 52.3%
FY2023 $7.21 30.2%
FY2022 $6.31 29.8%
FY2021 $5.52 30.5%

UnitedHealth Group has been actively repurchasing shares, spending $52.77B on buybacks over the past 11 years.

See UnitedHealth Group's buyback history alongside shares outstanding below

UnitedHealth Group's Balance Sheet Health

Key Balance Sheet Metrics (FY2025)
Metric Value
Cash & Short-term Investments $28.12B
Total Debt $78.39B
Shareholders' Equity $94.11B
Total Assets $309.58B
Debt-to-Equity Ratio 0.83x
Current Ratio 0.79x
Interest Coverage 4.7x
Free Cash Flow (TTM) $16.07B

UnitedHealth Group has a debt-to-equity ratio of 0.83, a current ratio of 0.79, interest coverage of 4.7x in FY2025, which suggest adequate financial health with manageable leverage.

UnitedHealth Group carries significant leverage with $78.39B in total debt against $94.11B in equity (D/E: 0.83x). The $28.12B cash position provides some buffer.

The current ratio of 0.79x is on the lower side, suggesting UnitedHealth Group's short-term liquidity bears watching.

At 4.7x interest coverage, UnitedHealth Group has substantial headroom above its debt payments.

Strong free cash flow generation of $16.07B gives UnitedHealth Group financial flexibility for capital allocation.

Explore UnitedHealth Group's full balance sheet and cash flow analysis below

As of FY2025, UnitedHealth Group's workforce stood at 390,000, about $1.1M in revenue per employee.

See UnitedHealth Group's full employee count history and revenue per employee

Valuation Check: Is UnitedHealth Group Overpriced?

Is UnitedHealth Group overvalued? Let's see what the numbers say.

UnitedHealth Group shares are currently trading at $415.36.

Running the numbers through the P/E Ratio model gives a fair value of $297 for UnitedHealth Group.

We also calculate intrinsic value using the DCF and EPS Growth models. Sign up to see the full breakdown with fair value estimates.

Valuation Models
Model Est. Fair Value vs. Current Price
P/E Ratio $297 40.0% downside to fair value
DCF Upgrade Upgrade
EPS Growth Upgrade Upgrade

Key Takeaways

To sum up UnitedHealth Group's financial position: the data paints a clear picture for investors evaluating this health care stock.

Revenue of $447.57B in FY2025, up 11.8% year-over-year.

Long-term revenue has been compounding at 11.0% annually over 10 years.

The company is profitable, with a net margin of 2.7% and net income of $12.06B.

Returned $13.46B to shareholders in FY2025 through dividends and/or buybacks.

Conservative balance sheet with a D/E ratio of 0.83x.

The P/E Ratio model implies 40.0% downside to fair value. The remaining 2 models are worth cross-checking before drawing a conclusion. Sign up to see the full analysis.

Explore UnitedHealth Group's complete financial data, including valuation models and historical trends, in the charts below.

Frequently Asked Questions

How much revenue does UnitedHealth Group generate?
UnitedHealth Group generated $447.57B in revenue during FY2025.
How much does UnitedHealth Group earn per share?
UnitedHealth Group's diluted earnings per share (EPS) were $13.23 in FY2025.
Does UnitedHealth Group pay a dividend?
Yes, UnitedHealth Group pays a regular dividend to shareholders.
What is the fair value of UnitedHealth Group stock?
Based on the P/E ratio model, UnitedHealth Group appears overvalued, trading at a 42% premium to its estimated fair value of $296.
What sector is UnitedHealth Group in?
UnitedHealth Group (UNH) operates in the Health Care sector, specifically in the Managed Health Care industry.

What does UnitedHealth Group do?

UnitedHealth Group operates the largest U.S. health insurer through UnitedHealthcare, offering benefit plans to employers, individuals, and government programs including Medicaid and Medicare. Its Optum division spans direct care delivery (Optum Health), healthcare technology and analytics (Optum Insight), and pharmacy benefit management (Optum Rx).

Detailed Charts

UnitedHealth Group Performance

5-year trend showing revenue, gross profit, and net profit

FY2021 – FY2025

UnitedHealth Group's revenue grew 11.8% to $447.57B in FY2025, but net profit declined 16.3% to $12.06B — indicating margin compression.

Understanding Company Performance

Revenue is UnitedHealth Group's total income from operations. Gross Profit is revenue minus cost of goods sold — the higher it is relative to revenue, the stronger the company's pricing power. Net Profit is the bottom line after all expenses, taxes, and interest. Consistent growth across all three signals a healthy, expanding business. Compare with peers in the same sector.

Is UnitedHealth Group Profitable?

5-year trend showing gross, operating, and net profit margins

FY2021 – FY2025

UnitedHealth Group's net profit margin of 2.7% in FY2025 reflects weak profitability, with operating margin at 4.2% and gross margin at 18.5%.

Understanding Profitability Margins

Gross Profit Margin (GPM) shows what percentage of UnitedHealth Group's revenue remains after direct production costs. Operating Profit Margin (OPM) factors in operating expenses like R&D and SG&A. Net Profit Margin (NPM) is the final profitability after all costs including interest and taxes. Stable or improving margins indicate pricing power and cost discipline.

UnitedHealth Group Revenue & Earnings Growth

5-year trend showing revenue and diluted EPS

FY2021 – FY2025

UnitedHealth Group's revenue grew 11.8% YoY in FY2025, but EPS declined 14.7%, indicating margin pressure.

Understanding Revenue & Earnings Growth

Revenue is UnitedHealth Group's total income from operations — the top line. Diluted EPS (Earnings Per Share) is net income divided by all shares that could exist if stock options, RSUs, and convertibles were exercised. Revenue shows how fast the business is growing; EPS shows how much of that growth reaches shareholders after all costs and dilution. Healthy companies tend to grow both in tandem; when revenue grows but EPS shrinks, margins are compressing. Use our stock screener to compare growth profiles across companies.

UnitedHealth Group Compound Annual Growth Rate (CAGR)

Metric 1-Year 5-Year 10-Year
Revenue +11.8% +11.7% +11.0%
Net Income -16.3% -4.8% +7.6%
EPS -14.7% -3.8% +8.2%
Share Price +78.4% +1.5% +13.1%

UnitedHealth Group's 10-year revenue CAGR of 11.0% reflects healthy long-term growth, though EPS CAGR of 8.2% trails revenue, suggesting rising costs eating into profits. The share price has compounded at 13.1% annually over a comparable period, broadly tracking fundamentals.

UnitedHealth Group Quarterly Performance

Quarterly revenue and net income with a weekly share-price overlay

Upgrade to see the full 5 years (20 quarters) of quarterly data.

FY2025 – FY2026

How to Read Quarterly Performance

Quarterly revenue and net income are UnitedHealth Group's most recent three-month results. Each bar shows net income nested inside revenue, since profit is the slice of revenue left after all costs; the taller the green portion relative to the blue, the more of each sales dollar reached the bottom line. A bar below zero is a quarterly loss.

For a long-term view, compare each quarter with the same quarter a year earlier (year-over-year), not with the previous quarter — sequential change is mostly seasonality (for many businesses the holiday quarter is always the biggest). Then watch the trend across several years: is year-over-year revenue growth accelerating or fading; is net income growing at least as fast as revenue (expanding vs compressing margins)? One quarter is noise — the multi-quarter trend is the signal.

UnitedHealth Group Share Price vs Book Value

UnitedHealth Group (UNH) share price vs book value per share — FY2016 – FY2025

Understanding Share Price vs Book Value

Share Price is what the market pays per share of UnitedHealth Group. Book Value per Share (BVPS) is the company's net equity divided by diluted shares — the accounting floor if the company were liquidated today. When price tracks close to book value the market sees the company as a steady asset; when price runs far above book the market is paying up for expected future earnings. For banks, book value is the primary valuation anchor; for most other companies it's one signal among many.

Unlock Valuation Analysis

Get fair value estimates from multiple valuation models and see whether a stock is undervalued or overvalued.

  • Multi-model fair value estimates (P/E, DCF, EPS Growth)
  • Undervalued/overvalued assessment with upside potential
  • Compare fair values across methodologies

UnitedHealth Group Free Cash Flow

5-year trend — cash generated after reinvestment

FY2021 – FY2025

UnitedHealth Group's free cash flow of $16.08B in FY2025 represents a 3.6% FCF margin, leaving limited capacity for shareholder returns after reinvestment.

Understanding Free Cash Flow

Free Cash Flow (FCF) is UnitedHealth Group's operating cash flow minus capital expenditure — the cash left over after maintaining and growing the business. Unlike net profit, FCF strips out non-cash items (depreciation, stock-based compensation) and includes actual cash spent on assets. Positive FCF means the company can pay dividends, buy back shares, reduce debt, or make acquisitions without raising capital. Consistently negative FCF signals the company is burning cash and may need external funding.

UnitedHealth Group Financial Ratios

Balance sheet strength and debt servicing capacity

FY2021 – FY2025

Debt-to-Equity

0.83

→ stable

Current Ratio

0.79

▼ from 0.83

Interest Coverage

4.7x

▼ from 8.27

UnitedHealth Group has a debt-to-equity ratio of 0.83, a current ratio of 0.79, interest coverage of 4.7x in FY2025, which suggest adequate financial health with manageable leverage.

Understanding Financial Health

Debt-to-Equity (D/E) measures how much debt the company carries relative to shareholder equity — lower means less leverage risk. Current Ratio divides current assets by current liabilities — above 1.0 means the company can cover short-term obligations. Interest Coverage is operating income divided by interest expense — higher means the company earns well above its debt payments. Together these three metrics reveal whether a company can weather downturns without financial distress.

UnitedHealth Group Shares Outstanding

Diluted share count per fiscal year — labels show year-over-year change

FY2021 – FY2025

UnitedHealth Group's diluted shares decreased 2.0% YoY in FY2025, indicating shareholder-friendly buybacks.

Understanding Shares Outstanding

Diluted shares outstanding counts every share of UnitedHealth Group that could exist if all stock options, RSUs, and convertibles were exercised. A shrinking count signals buybacks (returning cash to shareholders by reducing the denominator of EPS). A growing count signals dilution — usually from stock-based compensation, secondary offerings, or stock-funded acquisitions. Routine 1–2% growth is typical at large-cap tech companies that pay employees in equity; sustained growth above 5% warrants a look at the cause.

Unlock Full Analysis

Unlock 10-year interactive charts, all 5 valuation models, and full screener access.